Gwangju, South Korea

Bu Soo Park

This inventor holds 1 USPTO granted patent. Top assignee: Samyang Genex Corporation. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bu Soo Park. Retrieved from https://idiyas.com/inventor/bu-soo-park-ymohodhf

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Bu Soo Park in the Field of Biochemistry

Introduction

Bu Soo Park is a notable inventor based in Kwangju, South Korea. He has made significant contributions to the field of biochemistry, particularly in the detection of specific compounds. His work has implications for various diagnostic applications, showcasing the importance of innovation in medical technology.

Latest Patents

Bu Soo Park holds a patent for a "Composition for detecting β-1,3-glucan." This invention relates to a composition that can detect infinitesimal quantities of β-1,3-glucan, along with a preparation method and a diagnostic kit for its detection. The composition demonstrates phenoloxidase activity in the presence of calcium ions, allowing for the detection of β-1,3-glucan by measuring this activity in a sample.

Career Highlights

Bu Soo Park is associated with Samyang Genex Corporation, where he continues to work on innovative solutions in biochemistry. His expertise and dedication to research have positioned him as a valuable asset in his field.

Collaborations

He collaborates with notable colleagues, including Joong Hyuck Auh and Chang Hun Joo, contributing to a dynamic research environment that fosters innovation.

Conclusion

Bu Soo Park's contributions to the detection of β-1,3-glucan exemplify the critical role of inventors in advancing medical diagnostics. His work not only enhances our understanding of biochemical processes but also paves the way for future innovations in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…